PATENT CLAIM ANALYSIS

Application Number: 15876401
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["549", "282000"]

Abstract:
Psoralen compounds of compounds having formulae 1A-10A, 1B-10B, 1C-10C, 1D-10D, 1E-10E, 1F-10F, 1G-10G, and 1H-5H as shown in FIG.  1,  and pharmaceutically acceptable salts thereof; and their use in methods for the treatment of a cell proliferation disorder in a subject, pharmaceutical compositions containing the psoralen derivatives, a kit for performing the method, and a method for causing an autovaccine effect in a subject using the method.

Claim (Index 1):
A method for treating a cell proliferation disorder in a subject, comprising:\n (1) administering to the subject a psoralen compound selected from the group consisting of compounds having the following formulas: and\n a pharmaceutically acceptable salt thereof, that effects a predetermined cellular change when activated; and \n (2) applying an initiation energy from an initiation energy source to the subject, activating the psoralen compound in situ, \n thus causing the predetermined cellular change to occur, wherein occurrence of the predetermined cellular change causes an increase or decrease in a rate of cell proliferation to treat the cell proliferation disorder.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 86.0
- Lexical Diversity: 1.62
- Patent Class: 549.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11935655', '14603539', '14573511', '15786046', '13054279']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7106176177801757
- 35 USC 102 Novelty (BERT): 0.5383926838340491
- Combined Prediction Score: 0.693395124385563
- Mean Citation Score: 360.017622
- Max Citation Score: 367.34283
- Similarity Product: 308.6189618103325

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test